AU2005226605A1 - Novel process - Google Patents
Novel process Download PDFInfo
- Publication number
- AU2005226605A1 AU2005226605A1 AU2005226605A AU2005226605A AU2005226605A1 AU 2005226605 A1 AU2005226605 A1 AU 2005226605A1 AU 2005226605 A AU2005226605 A AU 2005226605A AU 2005226605 A AU2005226605 A AU 2005226605A AU 2005226605 A1 AU2005226605 A1 AU 2005226605A1
- Authority
- AU
- Australia
- Prior art keywords
- alkyl
- formula
- amino
- hydroxy
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/66—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
Description
WO 2005/092879 PCT/SE2005/000415 -1 FIELD OF INVENTION The present invention provides a novel process for the preparation of chromone compounds having the general formula I: 0 R - %R 2 5 L 0 wherein
R
1 is selected from H, C1.1oalkyl, halogen, amino, C1..
6 alkyl-oxy, or hydroxy; L is a displaceable group selected from bromo, chloro, fluoro or iodo; and 10 R 2 is selected from H, C1.
6 alkyl, halogen, hydroxy, amino, CI 6 alkyl-amino, C1.6alkyl carbonyl, C1..
6 alkyl-oxy and CI.6alkyl-oxycarbonyl optionally substituted by one or more groups selected from halogen, amino and hydroxy; BACKGROUND OF THE INVENTION 15 The present invention relates to the preparation of chromone compounds that may be useful in the manufacture of potentially potent orally active 5-Htlb receptor antagonist, useful in the treatment of depression, anixiety and other related diseases. An example of such a preparation is as follows: 20 0 0 F 1. DMADC F 1. H2SO4 F Isopropanol OH 2. EtOH EtaNj I OH O OH 0 OEt 2. NaOH/H 2 0 Br Br 0 Br 0 X II While this preparation leads to the chromone compound it also suffers from several drawbacks, making its viability for commercial production doubtful.
WO 2005/092879 PCT/SE2005/000415 -2 Applicants provide a process for the preparation of chromone compounds of formula I that unexpectedly and surprisingly provide improvements in product yields, cost, energy consumption, reduction in the number of synthetic steps, improved scale up conditions, and 5 the like. 10 DESCRIPTION OF THE INVENTION Provided herein is a process for preparing compounds of formula I: 0
R
1 R L 0 1 15 wherein R1 is selected from H, C1..oalkyl, halogen, amino, C1.6alkyl-oxy, or hydroxy; L is a displaceable group selected from bromo, chloro, fluoro or iodo; and
R
2 is selected from H, C 1
.
6 alkyl, halogen, hydroxy, amino, C16alkyl-amino, C-6alkyl 20 carbonyl, CI 6 alkyl-oxy and C1.6alkyl-oxycarbonyl optionally substituted by one or more groups selected from halogen, amino and hydroxy; comprising 25 A) heating a mixture of a compound of formula Va: WO 2005/092879 PCT/SE2005/000415 -3 R OH L Va, and an acetylating agent in the presence of a Lewis acid catalyst at a temperature and for a time effective to give compounds of formula Vb: 5 0 R~ CH 3 OH L Vb B) combining the compounds of formula Vb and a dicarbonyl compound to an alcohol solution at a temperature and for a time effective to give compounds of formula Vc: 10 0 0 R 2 -9 OH L Vc, and C) heating the compound of formula Vc with a mixture of acids at a temperature and for a time effective to give compounds of formula 1. 15 In another embodiment, R 1 is, independently, H, C 1
-C
6 alkyl, halogen, hydroxyl, methoxy or cyano. In a more particular embodiment R' is, independently, hydrogen or fluoro. In another embodiment, L is a displaceable group. In another embodiment L is a 20 displaceable group selected from bromo, chloro, fluoro or iodo. In a more particular embodiment L is bromo.
WO 2005/092879 PCT/SE2005/000415 -4 In another embodiment, R 2 is selected from H, C1.
6 alkyl, halogen, hydroxy, amino or Cp.6alkyl-oxy optionally substituted by one or more groups selected from halogen, amino and hydroxy. In a more particular embodiment, R 2 is selected from H, Ci.
6 alkyl, C1.
6 alkyl-oxy or 5 hydroxy. If necessary a number of different bases and solvents can be used for the above process. The above process may further include a step for separating, filtering or washing compounds that may be carried out in any number of ways known in the art. 10 In another embodiment, heating the compound of formula Va, the acetylating agent and the catalyst may be conducted at a temperature and for a time effective to provide compound Vb. In a more particular embodiment, the heating of formula Va, the acetylating agent and the catalyst may be conducted at a temperature between about 130 and about 135*C 15 for about 1 to 2 hours. In another embodiment, the acetylating agent are those functional derivatives of carboxylic acids that contain an acyl group and that can undergo nucleophilic substitution. For example, suitable acetylating agents include acetic acid, acetic anhydride, acetamide, acetyl 20 chloride, acetyl bromide and ethyl acetate. In a more particular embodiment, the acetylating agent may be acetyl chloride. In another embodiment, the Lewis acid catalyst may be selected from aluminum chloride, zirconium tetrachloride, bromide tetrachloride, HF and phosphoric acid. In a more 25 particular embodiment, the Lewis acid catalyst may be selected from aluminum chloride or zirconium tetrachloride. In particular, the Lewis acid catalysts may be aluminum chloride. In another embodiment the Lewis acid catalyst may be added in portions. In particular, the Lewis acid catalyst may be added in two portions. 30 In another embodiment, the pH level may be adjusted. In another embodiment, the pH level may be adjusted to about 7.
WO 2005/092879 PCT/SE2005/000415 -5 In another embodiment, one of the carbonyl groups forming the dicarbonyl compound may be an ester. For example, suitable dicarbonyl compounds include Pyruvate or glyoxylate esters, methylglyoxal, and C 14 oxalate. In particular, the dicarbonyl compound may be ethyl 5 oxalate. In another embodiment, reacting the compound of formula Vb with a dicarbonyl compound in an alcohol solution may be conducted at a temperature and for a time effective to provide compound Vc. In a more particular embodiment, the reaction may be conducted at 10 a temperature between about 55 and about 60'C for a time between about 1 to 2 hours. In another embodiment, the alcohol solution comprises sodium alkoxide in absolute alcohol. For example, suitable sodium alkoxides include sodium methoxide, sodium ethoxide sodium isopropoxide and sodium tert-butoxide. For example, suitable absolute alcohols 15 include methanol, ethanol, propanol, butanol, isobutanol and tert-butanol. In particular, the alcohol solution comprises sodium ethoxide in absolute ethanol. In another embodiment, reacting the compound of formula Vc with a mixture of acid may be conducted at a temperature and for a time effective to provide compound I. In a more 20 particular embodiment, the reaction may be conducted at a temperature between about 70 and about 80'C for a time between about 1 to 2 hours. In another embodiment, the mixture of acids may be a mixture of acetic and hydrochloric acid. 25 Minimizing the charge of aluminum chloride may help control any impurities that form during the above process. Unless specified otherwise within this specification, the nomenclature used in this 30 specification generally follows the examples and rules stated in Nomenclature of Organic Chemistry, Sections A, B, C, D, E, F, andH, Pergamon Press, Oxford, 1979, which is WO 2005/092879 PCT/SE2005/000415 -6 incorporated by references herein for its exemplary chemical structure names and rules on naming chemical structures. The term "alkyl" used alone or as a suffix or prefix, refers to monovalent straight or 5 branched chain hydrocarbon radicals comprising 1 to about 12 carbon atoms. Unless otherwise specified, "alkyl" generally includes both saturated alkyl and unsaturated alkyl. The term "cycloalkyl," used alone or as suffix or prefix, refers to a monovalent ring containing hydrocarbon radical comprising at least 3 up to about 12 carbon atoms. 10 The term "aryl" used alone or as suffix or prefix, refers to a hydrocarbon radical having one or more polyunsaturated carbon rings having aromatic character, (e.g., 4n + 2 delocalized electrons) and comprising 5 up to about 14 carbon atoms, wherein the radical is located on a carbon of the aromatic ring. 15 The term "heterocycle" used alone or as a suffix or prefix, refers to a ring-containing structure or molecule having one or more multivalent heteroatoms, independently selected from N, 0, P and S, as a part of the ring structure and including at least 3 and up to about 20 atoms in the ring(s). Heterocycle may be saturated or unsaturated, containing one or more 20 double bonds, and heterocycle may contain more than one ring. When a heterocycle contains more than one ring, the rings may be fused or unfused. Fused rings generally refer to at least two rings share two atoms therebetween. Heterocycle may have aromatic character or may not have aromatic character. 25 The term "alkoxy" used alone or as a suffix or prefix, refers to radicals of the general formula -0-R, wherein -R is selected from a hydrocarbon radical. Exemplary alkoxy includes methoxy, ethoxy, propoxy, isopropoxy, butoxy, t-butoxy, isobutoxy, cyclopropylmethoxy, allyloxy, and propargyloxy. 30 Halogen includes fluorine, chlorine, bromine and iodine.
WO 2005/092879 PCT/SE2005/000415 -7 When a first group, structure, or atom is "directly connected" to a second group, structure or atom, at least one atom of the first group, structure or atom forms a chemical bond with at least one atom of the second group, structure or atom. 5 "Saturated carbon" means a carbon atom in a structure, molecule or group wherein all the bonds connected to this carbon atom are single bond. In other words, there is no double or triple bonds connected to this carbon atom and this carbon atom generally adopts an sp3 atomic orbital hybridization. 10 "Unsaturated carbon" means a carbon atom in a structure; molecule or group wherein at least one bond connected to this carbon atom is not a single bond. In other words, there is at least one double or triple bond connected to this carbon atom and this carbon atom generally adopts a sp or sp 2 atomic orbital hybridization. 15 The processes and synthetic methods described hereinthroughout may be carried out with or without a suitable solvent or base. Generally, suitable solvents are solvents which are substantially non-reactive with the starting materials (reactants), the intermediates, or products at the temperatures at which the reactions are carried out, i.e., temperatures which may range from the solvent's freezing temperature to the solvent's boiling temperature. 20 A given reaction may be carried out in one solvent or a mixture of more than one solvent. Depending on the particular reaction, suitable solvents for a particular work-up following the reaction may be selected. For example, suitable solvents may include water, alcohols, hydrocarbon solvents and halogenated derivatives. In particular, water, 25 dichloromethane, xylene, ethanol and methanol. Examples Preparation ofl-(3-bromo-5-fluoro-2-hydroxyphenyl)ethanone 30 WO 2005/092879 PCT/SE2005/000415 -8 A mixture of 2-bromo-4-fluorophenol (64.0 kg, 1.00 mol equiv) and acetyl chloride (62.5 kg, 2.39 mol equiv) was stirred and heated at 50-55*C for one hour. Excess acetyl chloride (10.8 kg) was removed by distillation and the residue was cooled to 25-30 0 C then diluted with dichloromethane (120 L). The mixture was further cooled to 10-15*C and 5 aluminum chloride (51.0 kg, 1.15 mol equiv) was added in two portions. The temperature of the mixture was raised to 130-1 35*C over one hour during which time dichloromethane (80 L) was removed by distillation. The mixture was maintained at 130-135*C for one hour, diluted with xylene (250 L) and cooled to 10-15*C. The reaction mixture was added to a solution of 30% w/w hydrochloric acid (25 L) in water (500 L). The layers were separated 10 and the organic phase was extracted with 10% w/w sodium hydroxide solution (300 L). The aqueous extract was cooled to 10-15 C and adjusted to pH 6.8-7.2 with 30% w/w hydrochloric acid (55.0 kg). The solid was filtered off, washed with water (60 L), then with petroleum ether (100 L) and dried at 55-60*C under vacuum. The yield of 1-(3-bromo-5 fluoro-2-hydroxyphenyl)ethanone was 46.0 kg (60%). 15 Preparation of ethyl 8 -bromo-6-fluoro-4-oxo-4H-chromene-2-carboxylate A mixture of 1-(3-bromo-5-fluoro-2-hydroxyphenyl)ethanone (46.0 kg, 1.00 mol equiv) and diethyl oxalate (172.0 kg, 6.00 mol equiv) was added to a solution of sodium 20 ethoxide (66.8 kg, 4.9 mol equiv) in absolute ethanol (250 L) at 60'C. The mixture was stirred at 55-60'C for one hour and ethanol was removed by distillation. The residual mixture was diluted with water (300 L) and the precipitated solid isolated by filtration. This solid was heated with a mixture of acetic acid (210 L) and 30 w/w hydrochloric acid (55.5 L) at 70 80*C for two hours. After cooling at 25'C, the mixture was diluted with water (150 L and 100 25 L), then with 12% w/w sodium bicarbonate solution (50 L) and finally methanol (100 L) before drying at 70*C under vacuum. The yield of ethyl 8-bromo-6-fluoro-4-oxo-4H chromene-2-carboxylate was 38.6 kg (63%).
Claims (8)
1. A process of preparing a compound of formula I: 0 L 0 5 wherein R' is selected from H, C1-10alkyl, halogen, amino, C1. 6 alkyl-oxy, or hydroxy; L is a displaceable group selected from bromo, chloro, fluoro or iodo; and R 2 is selected from H, C 1 6 alkyl, halogen, hydroxy, amino, C16alkyl-amino, CI. 6 alkyl 10 carbonyl, C1. 6 alkyl-oxy and C.6alkyl-oxycarbonyl optionally substituted by one or more groups selected from halogen, amino and hydroxy; comprising: 15 A) heating a mixture of a compound of formula Va: R1 OH L Va, and acetylating agent in the presence of a Lewis acid catalyst at a temperature and for 20 a time effective to give compounds of formula Vb: WO 2005/092879 PCT/SE2005/000415 -10 0 R~ CH 3 Ri OH L Vb, B) combining the compounds of formula Vb and a dicarbonyl compound to an alcohol solution at a temperature and for a time effective to give compounds of formula Vc: 5 0 0 OH L Vc, and C) heating the compound of formula Vc with a mixture of acids at a temperature and for a time effective to give compounds of formula I. 10
2. A process according to claim 1, wherein R' is, independently, hydrogen or fluoro.
3. A process according to claim 1, wherein R 2 is, independently, H, CI 6 alkyl, CI 6 alkyl oxy or hydroxy.
4. A process according to claim 1, wherein L is bromo. 15 5. A process of preparing a compound of formula I: 0 RR 2 L O wherein R 1 is selected from H, C 1 1 oalkyl, halogen, amino, CI. 6 alkyl-oxy, or hydroxy; 20 L is a displaceable group selected from bromo, chloro, fluoro or iodo; and WO 2005/092879 PCT/SE2005/000415 -11 R2 is selected from H, C 1 . 6 alkyl, halogen, hydroxy, amino, C1. 6 alkyl-amino, CI. 6 alkyl carbonyl, CI 6 alkyl-oxy and C 1 . 6 alkyl-oxycarbonyl optionally substituted by one or more groups selected from halogen, amino and hydroxy; 5 comprising: A) heating a mixture of a compound of formula Va: RI OH L Va, 10 and acetyl chloride in the presence of either aluminum chloride or zirconium tetrachloride at a temperature and for a time effective to give compounds of formula Vb: 0 CH 3 OH 15 L Vb B) combining the compounds of formula Vb and diethyl oxalate to a solution of sodium ethoxide in absolute ethanol at a temperature and for a time effective to give compounds of formula Vc: 20 0 a R 2 RI OH L Ve, and WO 2005/092879 PCT/SE2005/000415 -12 C) heating the compound of formula Vc with a mixture of acetic acid and hydrochloric acid at a temperature and for a time effective to give compounds of formula I.
5
6. A process according to claim 5, wherein R 1 is, independently, hydrogen or fluoro.
7. A process according to claim 5, wherein R2 is, independently, H, C 1 . 6 alkyl, CI- 6 alkyl oxy or hydroxy.
8. A process according to claim 5, wherein L is bromo. 10
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0400786A SE0400786D0 (en) | 2004-03-25 | 2004-03-25 | Novel Process for the preparation of a chromone intermediate |
SE0400786-0 | 2004-03-25 | ||
PCT/SE2005/000415 WO2005092879A1 (en) | 2004-03-25 | 2005-03-22 | Novel process |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2005226605A1 true AU2005226605A1 (en) | 2005-10-06 |
Family
ID=32067537
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2005226605A Abandoned AU2005226605A1 (en) | 2004-03-25 | 2005-03-22 | Novel process |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1732914A1 (en) |
JP (1) | JP2007530535A (en) |
KR (1) | KR20060129496A (en) |
CN (1) | CN1953970A (en) |
AU (1) | AU2005226605A1 (en) |
BR (1) | BRPI0509020A (en) |
CA (1) | CA2561160A1 (en) |
IL (1) | IL177963A0 (en) |
NO (1) | NO20064862L (en) |
RU (1) | RU2006135484A (en) |
SE (1) | SE0400786D0 (en) |
WO (1) | WO2005092879A1 (en) |
ZA (1) | ZA200607553B (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05255172A (en) * | 1992-03-16 | 1993-10-05 | Shell Internatl Res Maatschappij Bv | Manufacture of 3,6-dichloro-2-hydroxyacetophenone |
ATE169924T1 (en) * | 1993-05-18 | 1998-09-15 | Takeda Chemical Industries Ltd | BENZOPYRAN DERIVATIVES AND THEIR USE |
JPH07291983A (en) * | 1993-05-18 | 1995-11-07 | Takeda Chem Ind Ltd | Benzopyran derivative and medicine containing the same |
AU2001268162A1 (en) * | 2000-06-02 | 2001-12-17 | Cor Therapeutics, Inc. | Methods for producing chiral chromones, chromanes, amino substituted chromanes and intermediates therefor |
-
2004
- 2004-03-25 SE SE0400786A patent/SE0400786D0/en unknown
-
2005
- 2005-03-22 KR KR1020067019560A patent/KR20060129496A/en not_active Application Discontinuation
- 2005-03-22 CN CNA2005800096380A patent/CN1953970A/en active Pending
- 2005-03-22 AU AU2005226605A patent/AU2005226605A1/en not_active Abandoned
- 2005-03-22 BR BRPI0509020-2A patent/BRPI0509020A/en not_active IP Right Cessation
- 2005-03-22 JP JP2007504914A patent/JP2007530535A/en active Pending
- 2005-03-22 RU RU2006135484/04A patent/RU2006135484A/en not_active Application Discontinuation
- 2005-03-22 CA CA002561160A patent/CA2561160A1/en not_active Abandoned
- 2005-03-22 WO PCT/SE2005/000415 patent/WO2005092879A1/en active Application Filing
- 2005-03-22 EP EP05722256A patent/EP1732914A1/en not_active Withdrawn
-
2006
- 2006-09-07 IL IL177963A patent/IL177963A0/en unknown
- 2006-09-08 ZA ZA200607553A patent/ZA200607553B/en unknown
- 2006-10-25 NO NO20064862A patent/NO20064862L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL177963A0 (en) | 2006-12-31 |
WO2005092879A8 (en) | 2006-10-19 |
SE0400786D0 (en) | 2004-03-25 |
RU2006135484A (en) | 2008-05-10 |
CA2561160A1 (en) | 2005-10-06 |
WO2005092879A1 (en) | 2005-10-06 |
NO20064862L (en) | 2006-12-21 |
EP1732914A1 (en) | 2006-12-20 |
CN1953970A (en) | 2007-04-25 |
BRPI0509020A (en) | 2007-08-07 |
JP2007530535A (en) | 2007-11-01 |
KR20060129496A (en) | 2006-12-15 |
ZA200607553B (en) | 2008-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2049459B1 (en) | Novel process for the synthesis of (e)-stilbene derivatives which makes it possible to obtain resveratrol and piceatannol | |
JP5788381B2 (en) | A novel process for preparing hydroxylamine and drugs | |
KR101308258B1 (en) | A novel method of making Endoxifen | |
WO2016078505A1 (en) | Preparation method of fluorene ethyl ketone derivative | |
AU2005226605A1 (en) | Novel process | |
JP2018043989A (en) | Method of producing blonanserin | |
JP2641542B2 (en) | Method for producing asymmetric dihydropyridines | |
JP5463051B2 (en) | Method for producing 1,4-dihydropyridine derivative | |
CN110734364A (en) | Synthesis method of 1- (4-chlorphenyl) -2-cyclopropyl-1-acetone | |
MXPA06010734A (en) | Novel process | |
US20070197615A1 (en) | Process for the preparation of the PPAR alpha agonist NS-220 | |
JP2001302658A (en) | Method for manufacturing of 3-isochromanones | |
CN107176942B (en) | Preparation method of loxoprofen sodium and intermediate thereof | |
JPH08503939A (en) | Method for producing α-aryl-γ-butyrolactone | |
JPH06279414A (en) | Preparation of aryl hydantoin | |
KR100408431B1 (en) | Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one or pharmaceutically acceptable salts thereof | |
JPH10265433A (en) | Production of phenylpropionic acid derivative | |
JP3958109B2 (en) | Method for producing triazolopyrimidine derivative | |
CN116789595A (en) | Preparation process of special intermediate of montelukast sodium | |
EP2365746B1 (en) | Synthesis of (phenylalkyloxy)phenyl-oxobutanoic acids | |
JP3371009B2 (en) | Method for producing carboxylic acid derivative | |
CN113004227A (en) | Synthesis method of (2S,3S) -3- (tert-butyloxycarbonylamino) -1, 2-epoxy-4-phenylbutane | |
EP1948584B1 (en) | Process for the preparation of cyclopentanone derivatives | |
RU2277083C1 (en) | Method for preparing 5,8-dihydroxy-2,6,7-trimethoxy-3-ethyl-1,4-naphthoquinone | |
KR20070011824A (en) | Process for preparing dibenzothiepin derivatives and intermediates thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |